Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPhilipp Schüetz, Beat Müeller, Konrad Reinhart et al.|Cochrane Database of Systematic Reviews|2017Cited by 648
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysisPhilipp Schüetz, Beat Müeller, Yannick Wirz et al.|The Lancet Infectious Diseases|2017Cited by 473
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Raphaël Clère-Jehl, Maude Bouscambert‐Duchamp et al.|The Lancet Infectious Diseases|2021Cited by 344
Initial antimicrobial management of sepsisMichael S. Niederman, Girish B. Nair, Rebecca M. Baron et al.|Critical Care|2021Cited by 176
Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapyChristophe Adrie, Hakim Haouache, Maïté Garrouste-Orgeas et al.|Journal of Infection|2016Cited by 167